Skip to content

Clinical trials

Completed Choroidal Neovascularization trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Status: Completed Clear all

135 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20022
20033
20045
20059
200611
200716
200812
20094
201014
20116
20128
20137
20143
20156
20162
20173
20182
20193
20203
20216
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed135

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals19
National Eye Institute (NEI)10
Notal Vision Ltd.6
Novartis6
GlaxoSmithKline5
Johns Hopkins University5
Alcon Research4
Bayer4
Medical University of Vienna4
Allergan3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization135
Macular Degeneration86
Geographic Atrophy10
Vision Disorders9
Wet Macular Degeneration8
Macular Edema7
Myopia, Degenerative6
Retinal Vein Occlusion6
Angioid Streaks5
Diabetic Retinopathy5

Trials

Showing 76 to 100 of 135. Each trial links to its page on Pharma Observatory.

35 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.